Deals & Cases

Seed Financing Round in Premark Pharma GmbH

23 May 2019 – Walder Wyss advises Premark Pharma GmbH in connection with its seed financing round. The company focuses on developing topical treatments for skin and eye disease. The Financing Round was subscribed by private investors from Switzerland and abroad.

The Walder Wyss team comprises Alexander Gutmans (Partner, Corporate/M&A, Venture Capital), Vanessa C. Haubensak (Associate, Corporate/M&A) and Manuel Bigler (Associate, IP/IT).